Breast & Genitourinary Oncology at StElizabethNKY | Case Western Alum | Executive Board KYSCO | ASCOTECAG | cancerGRACE | Columnist at ASCO Connection | AI Enthusiasthttps://bsky.app/profile/matthewkurianmd.bsky.socialhttps://bsky.app/profile/matthewkurianmd.bsky.social/post/3ld4nrrlp5k2dFantastic event held yesterday by the @oncbrothers.bsky.social - truly thought provoking discussion with giants in the breast cancer space! Honored to be apart of it! @neil-iyengarmd.bsky.social @laurahuppert.bsky.so @drsgraff.bsky.social #sabcs2024 #signifymd12 Dec 2024 16:09 +0000at://did:plc:ercwm4ko3mxqaunxtitsu63e/app.bsky.feed.post/3ld4nrrlp5k2dhttps://bsky.app/profile/matthewkurianmd.bsky.social/post/3ld2avyjpek2jFantastic results from EMBER-3 showing response with abemaciclib + imlunestrant with ORR of 35% in combination for ESR1m HR+ adjuvant and ABC patients and specifically showed in those with ESR1m ⬆️PFS from 11.1m to 5.5m with combo vs oral SERD alone. #sabcs2024 @breastcancerdoc.bsky.social11 Dec 2024 17:13 +0000at://did:plc:ercwm4ko3mxqaunxtitsu63e/app.bsky.feed.post/3ld2avyjpek2jhttps://bsky.app/profile/matthewkurianmd.bsky.social/post/3lcydxtds6s2xNeed some simplification regarding ovarian suppression in premenopausal women? Nice summary by Prudence Francis from @petermaccc.bsky.social of who are candidates for OS + AI vs tamoxifen and timing of these agents is crucial! #sabcs202410 Dec 2024 23:03 +0000at://did:plc:ercwm4ko3mxqaunxtitsu63e/app.bsky.feed.post/3lcydxtds6s2xhttps://bsky.app/profile/matthewkurianmd.bsky.social/post/3lco77mytfs2bCongrats to all who’ve matched into heme/onc fellowship! Beginning of an exciting journey! If you are a future or current fellow deciding your career trajectory check out my commentary with colleagues as we discuss the differences in practice settings! https://connection.asco.org/do/navigating-your-career-path-after-fellowship-pros-and-cons-different-oncology-practice06 Dec 2024 22:11 +0000at://did:plc:ercwm4ko3mxqaunxtitsu63e/app.bsky.feed.post/3lco77mytfs2b